retatrutide patent Retatrutide Commercial Availability Timeline: Key

Dizziness during GLP-1 therapy is a reported side effect that typically appears in the first weeks of treatment

Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders worldwide

A Doral FL medical clinic compares Ozempic to tesamorelin, MOTS-c, and CJC-1295/Ipamorelin.

Study Selection We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study

A study of nearly 1.1 million people found that semaglutide (the drug in Ozempic and Wegovy) was associated with a 40-70% lower risk of developing Alzheimer's compared to other diabetes medications